BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 17266100)

  • 1. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis.
    Gonzalez-Gay MA; Gonzalez-Juanatey C; Lopez-Diaz MJ; Piñeiro A; Garcia-Porrua C; Miranda-Filloy JA; Ollier WE; Martin J; Llorca J
    Arthritis Rheum; 2007 Feb; 57(1):125-32. PubMed ID: 17266100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent chronic inflammation contributes to the development of cancer in patients with rheumatoid arthritis from a defined population of northwestern Spain.
    Llorca J; Lopez-Diaz MJ; Gonzalez-Juanatey C; Ollier WE; Martin J; Gonzalez-Gay MA
    Semin Arthritis Rheum; 2007 Aug; 37(1):31-8. PubMed ID: 17360028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis.
    Gonzalez-Gay MA; Llorca J; Palomino-Morales R; Gomez-Acebo I; Gonzalez-Juanatey C; Martin J
    Clin Exp Rheumatol; 2009; 27(1):116-9. PubMed ID: 19327239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.
    Khani-Hanjani A; Lacaille D; Horne C; Chalmers A; Hoar DI; Balshaw R; Keown PA
    J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between HLA-DRB1*15 and secondary Sjögren's syndrome in patients with rheumatoid arthritis.
    Mattey DL; González-Gay MA; Hajeer AH; Dababneh A; Thomson W; García-Porrúa C; Ollier WE
    J Rheumatol; 2000 Nov; 27(11):2611-6. PubMed ID: 11093441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
    Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
    Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis.
    Carroll L; Frazer IH; Turner M; Marwick TH; Thomas R
    Arthritis Res Ther; 2007; 9(2):R39. PubMed ID: 17425804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide.
    van der Helm-van Mil AH; Verpoort KN; le Cessie S; Huizinga TW; de Vries RR; Toes RE
    Arthritis Rheum; 2007 Feb; 56(2):425-32. PubMed ID: 17265477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients.
    Rodríguez-Rodríguez L; García-Bermúdez M; González-Juanatey C; Vazquez-Rodriguez TR; Miranda-Filloy JA; Fernández-Gutierrez B; Llorca J; Martín J; González-Gay MA
    Tissue Antigens; 2011 Apr; 77(4):291-7. PubMed ID: 21388351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.
    Nicola PJ; Maradit-Kremers H; Roger VL; Jacobsen SJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2005 Feb; 52(2):412-20. PubMed ID: 15692992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis.
    Maksymowych WP; Suarez-Almazor ME; Buenviaje H; Cooper BL; Degeus C; Thompson M; Russell AS
    J Rheumatol; 2002 Nov; 29(11):2319-26. PubMed ID: 12415587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of HLA-DRB1 shared epitope alleles and chronic inflammation to the increased incidence of cardiovascular disease in rheumatoid arthritis: comment on the article by Farragher et al.
    Gonzalez-Gay MA; Gonzalez-Juanatey C; Llorca J; Ollier WE; Martin J
    Arthritis Rheum; 2008 Aug; 58(8):2584; author reply 2584-5. PubMed ID: 18668593
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and predictors of mortality in rheumatoid arthritis--a role for mannose-binding lectin?
    Troelsen LN; Garred P; Jacobsen S
    J Rheumatol; 2010 Mar; 37(3):536-43. PubMed ID: 20110521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular death in rheumatoid arthritis: a population-based study.
    Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis.
    Kremers HM; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2004 Nov; 50(11):3450-7. PubMed ID: 15529378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
    Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between RANKL and HLA-DRB1 genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort.
    Wu H; Khanna D; Park G; Gersuk V; Nepom GT; Wong WK; Paulus HE; Tsao BP
    Arthritis Rheum; 2004 Oct; 50(10):3093-103. PubMed ID: 15476205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.
    Wållberg-Jonsson S; Johansson H; Ohman ML; Rantapää-Dahlqvist S
    J Rheumatol; 1999 Dec; 26(12):2562-71. PubMed ID: 10606363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of HLA-DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritis.
    Harrison B; Thomson W; Symmons D; Ollier B; Wiles N; Payton T; Barrett E; Silman A
    Arthritis Rheum; 1999 Oct; 42(10):2174-83. PubMed ID: 10524690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.